These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19603607)

  • 1. [MULTISTRATEGY and FATA: merits, limits and troubles of no profit clinical trials in acute myocardial infarction].
    Savonitto S
    G Ital Cardiol (Rome); 2009 Jun; 10(6):364-5. PubMed ID: 19603607
    [No Abstract]   [Full Text] [Related]  

  • 2. [The FATA study].
    Merlini PA; Valgimigli M
    G Ital Cardiol (Rome); 2009 Jun; 10(6):358-63. PubMed ID: 19603606
    [No Abstract]   [Full Text] [Related]  

  • 3. [The MULTISTRATEGY study].
    Danzi GB; Marzocchi A
    G Ital Cardiol (Rome); 2009 Jun; 10(6):353-7. PubMed ID: 19603605
    [No Abstract]   [Full Text] [Related]  

  • 4. [The FINESSE trial].
    Petronio AS; Piscione F
    G Ital Cardiol (Rome); 2009 Jan; 10(1):1-5. PubMed ID: 19292014
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanical reperfusion: treat well, treat on time too.
    Montalescot G
    Lancet; 2008 Aug; 372(9638):509-10. PubMed ID: 18707968
    [No Abstract]   [Full Text] [Related]  

  • 6. Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial).
    Taglieri N; Saia F; Guiducci V; Tondi S; Conrotto F; Marrozzini C; Rocchi G; Biagini E; Reggiani ML; Giacometti P; Piovaccari G; Manari A; Marzocchi A;
    Am J Cardiol; 2009 Mar; 103(6):785-90. PubMed ID: 19268732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TARGET trial: hit or miss?
    Moliterno DJ; Topol EJ
    Eur Heart J; 2002 Jun; 23(11):835-7. PubMed ID: 12042001
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials.
    De Luca G; Suryapranata H; Stone GW; Antoniucci D; Tcheng JE; Neumann FJ; Bonizzoni E; Topol EJ; Chiariello M
    J Am Coll Cardiol; 2006 Feb; 47(3):685-6. PubMed ID: 16458158
    [No Abstract]   [Full Text] [Related]  

  • 9. Tirofiban plus sirolimus-eluting stent vs abciximab plus bare-metal stent.
    Osman F; Qaisar S; El Gaylani N; Pitt M
    JAMA; 2005 Oct; 294(13):1616-7; author reply 1617-8. PubMed ID: 16204658
    [No Abstract]   [Full Text] [Related]  

  • 10. Tirofiban plus sirolimus-eluting stent vs abciximab plus bare-metal stent.
    De Luca L; Sardella G
    JAMA; 2005 Oct; 294(13):1617; author reply 1617-8. PubMed ID: 16204659
    [No Abstract]   [Full Text] [Related]  

  • 11. Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up.
    Mukherjee D; Topol EJ; Bertrand ME; Kristensen SD; Herrmann HC; Neumann FJ; Yakubov SJ; Bassand JP; McClure RR; Stone GW; Ardissino D; Moliterno DJ;
    Eur Heart J; 2005 Dec; 26(23):2524-8. PubMed ID: 16107485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitated PCI: crossing the bridge with lessons learned.
    Mishra S; Bahl VK
    Indian Heart J; 2009; 61(5):410-2. PubMed ID: 20635753
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tirofiban or abciximab and sirolimus-eluting or bare metal uncoated stents in primary percutaneous coronary intervention for acute myocardial infarction: results of MULTISTRATEGY trial].
    Iavelov IS
    Kardiologiia; 2008; 48(7):59-61. PubMed ID: 18789031
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.
    Montalescot G; Barragan P; Wittenberg O; Ecollan P; Elhadad S; Villain P; Boulenc JM; Morice MC; Maillard L; Pansiéri M; Choussat R; Pinton P;
    N Engl J Med; 2001 Jun; 344(25):1895-903. PubMed ID: 11419426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary stenting and abciximab in primary angioplasty for ST-segment-elevation myocardial infarction.
    De Luca G; Suryapranata H; Grimaldi R; Chiariello M
    QJM; 2005 Sep; 98(9):633-41. PubMed ID: 16040669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial.
    Ferrante G; Presbitero P; Corrada E; Campo G; Bolognese L; Vassanelli C; Colangelo S; De Cesare N; E Rodriguez A; Bramucci E; Moreno R; Piva T; Sheiban I; Pasquetto G; Prati F; Nazzaro MS; Ferrari R; Valgimigli M
    Am Heart J; 2012 Jan; 163(1):104-11. PubMed ID: 22172443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the use of abciximab in percutaneous coronary intervention.
    Iversen AZ
    Dan Med Bull; 2011 Aug; 58(8):B4312. PubMed ID: 21827726
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
    Topol EJ; Moliterno DJ; Herrmann HC; Powers ER; Grines CL; Cohen DJ; Cohen EA; Bertrand M; Neumann FJ; Stone GW; DiBattiste PM; Demopoulos L;
    N Engl J Med; 2001 Jun; 344(25):1888-94. PubMed ID: 11419425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study.
    Valgimigli M; Campo G; Arcozzi C; Malagutti P; Carletti R; Ferrari F; Barbieri D; Parrinello G; Percoco G; Ferrari R
    J Am Coll Cardiol; 2007 Jul; 50(2):138-45. PubMed ID: 17616297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does abciximab provide long-term benefit for patients with acute myocardial infarction treated with stents?
    Neumann FJ
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):190-1. PubMed ID: 16568126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.